IceCure Medical (ICCM) Return on Sales (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Return on Sales data on file, last reported at 0.05% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.05%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.04% (changed 0.0% YoY), and the FY2025 annual result was 0.04%, changed 0.0% from the prior year.
• Return on Sales improved to 0.05% in Q1 2026 per ICCM's latest filing, from 0.03% in the prior quarter.
• Over five years, Return on Sales peaked at 0.13% in Q3 2023 and troughed at 0.31% in Q4 2022.
• A 5-year average of 0.02% and a median of 0.05% in 2025 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2022 and 2024: Return on Sales declined 20 bps in 2022, then grew 27 bps in 2024.
• A 5-year view of Return on Sales shows it stood at 0.31% in 2022, then gained by 30 bps to 0.22% in 2023, then jumped by 123 bps to 0.05% in 2024, then sank by 36 bps to 0.03% in 2025, then jumped by 41 bps to 0.05% in 2026.
• Business Quant data shows ICCM's Return on Sales at 0.05% in Q1 2026, 0.03% in Q4 2025, and 0.05% in Q3 2025.